Premier Air Charter Holdings Inc. (PREM): Cost of Revenue

Annual figures by period end, from SEC filings.

$28.49M
Year ended 2025-12-31
$28.04M
Trailing 12 months to 2026-06-30
2024-12-31: $18.36M2025-12-31: $28.49M$28.49M
2024-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$28.49M+55.2%2026-04-15, From 2025-01-01
2024-12-31$18.36Mn/a2026-04-15, From 2024-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Premier Air Charter Holdings Inc. (PREM)2025-12-31$28.49M+55.2%
Orchestra BioMed Holdings, Inc. (OBIO)2025-12-31$190.0K-6.9%
ClearPoint Neuro, Inc. (CLPT)2025-12-31$14.28M+16.4%
Sensus Healthcare, Inc. (SRTS)2025-12-31$15.62M-10.1%
Cytosorbents Corp (CTSO)2025-12-31$10.57M-1.3%
Retractable Technologies Inc (RVP)2025-12-31$38.22M+12.2%
Utah Medical Products Inc (UTMD)2025-12-31$16.52M-1.4%
Interpace Biosciences, Inc. (IDXG)2025-12-31$14.60M-14.1%
KORU Medical Systems, Inc. (KRMD)2025-12-31$15.52M+26.1%

Compare PREM, OBIO, CLPT, SRTS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗